|
Market Cap (3-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 9 March 2021, 16:14. The announcement is marked as price sensitive, and is 2 page(s) in length and 231.9kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.169% short sold according to ASIC data. It was ranked the 392nd most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Immutep secures second US patent grant for eftilagimod alpha | 9 March 2021, 16:14 |
| Immutep expands Part B of TACTI-002 collaboration trial | 5 March 2021, 8:21 |
| Half Yearly Report and Accounts | 23 February 2021, 16:23 |
| Immutep Corporate Presentation | 2 February 2021, 8:22 |
You must be logged in to post a reply.
